Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis

Jalal Soubhye, Ibaa Chikh Alard, Pierre van Antwerpen, François Dufrasne
  • Future Medicinal Chemistry, August 2015, Future Science
  • DOI: 10.4155/fmc.15.74

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.4155/fmc.15.74

The following have contributed to this page: Dr Jalal Soubhye

In partnership with: